Get started
Author

Elaine Thrash

ORCID: 0009-0000-7690-7686
Observed ORCID: 0009-0000-7690-7686
OpenAlex ID: A5035532116
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
2023 · Glenn J. Hanna, Scott A. Roof, et al. · Clinical Cancer Research · 75
PDF
Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance
2024 · Scott A. Roof, James Jabalee, et al. · Oral Oncology · 21
Abstract PO-045: Utility of circulating tumor tissue modified viral (TTMV)-HPV DNA to resolve clinically indeterminate findings in patients following definitive treatment for HPV-driven oropharyngeal cancer
2023 · Scott Roof, Glenn Hanna, et al. · Clinical Cancer Research · 1
Utility of Early Post‐Treatment Circulating Tumor Tissue Modified Viral HPV DNA Testing in HPV ‐Associated Oropharyngeal Cancer
2026 · Scott A. Roof, James Jabalee, et al. · Head & Neck
PDF
Supplementary Figure S1 from Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
2025 · Glenn J. Hanna, Scott A. Roof, et al.
Abstract B022: Immediate post-treatment detection of minimal residual disease in HPV-Driven oropharyngeal cancer is associated with high risk of recurrence
2024 · Scott A Roof, James Jabalee, et al. · Clinical Cancer Research
Supplementary Figure S1 from Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
2024 · Glenn J. Hanna, Scott A. Roof, et al.
Data from Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
2024 · Glenn J. Hanna, Scott A. Roof, et al.
Data from Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
2023 · Glenn J. Hanna, Scott A. Roof, et al.
Supplementary Figure S1 from Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
2023 · Glenn J. Hanna, Scott A. Roof, et al.
Supplementary Figure S1 from Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
2023 · Glenn J. Hanna, Scott A. Roof, et al.
Data from Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
2023 · Glenn J. Hanna, Scott A. Roof, et al.
Abstract 3360: Negative predictive value of circulating tumor tissue modified viral HPV DNA for identifying recurrence among patients treated for HPV-driven oropharyngeal cancer
2023 · Glenn J. Hanna, Scott Roof, et al. · Cancer Research
Works count: 13
Citation count: 97
H-index: 2
I10-index: 2
Year
Topic
Type